Role of Omega-3 Fatty Acids on Lipid Profile in Diabetic Dyslipidaemia: Single Blind, Randomised Clinical Trial | Zendy

Shaylika Chauhan | Zendy; Hanish Kodali | Zendy; Jawad Noor | Zendy; Karuna Ramteke | Zendy; Vidisha Gawai | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Role of Omega-3 Fatty Acids on Lipid Profile in Diabetic Dyslipidaemia: Single Blind, Randomised Clinical Trial

Author(s) -

Shaylika Chauhan,

Hanish Kodali,

Jawad Noor,

Karuna Ramteke,

Vidisha Gawai

Publication year - 2017

Publication title -

journal of clinical and diagnostic research

Language(s) - English

Resource type - Journals

eISSN - 2249-782X

pISSN - 0973-709X

DOI - 10.7860/jcdr/2017/20628.9449

Subject(s) - postprandial , metformin , medicine , nausea , lipid profile , placebo , vomiting , gastroenterology , adverse effect , analysis of variance , omega 3 fatty acid , blood lipids , fatty acid , insulin , cholesterol , chemistry , biochemistry , polyunsaturated fatty acid , alternative medicine , pathology , docosahexaenoic acid

Diabetic dyslipidaemia is characterised by hypertriglyceridaemia, low High Density Lipoprotein (HDL), postprandial lipimea, small and dense LDL particles is considered to be a major predisposing factor for various macrovascular complications. Omega-3 fatty acids are fish oil derivative introduced in the market for dyslipidaemia associated with increased triglyceride level.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research